Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback